D Emil Kakkis

Affiliations

  • President & Ceo at Ultragenyx Pharmaceutical Inc. (RARE), 2025-03-05
  • Officer at Biomarin Pharmaceutical Inc (BMRN), 2009-03-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RARE $43.63 5,000 $218,150.00 472,479 2019-09-11 Filing
RARE $52.96 1,647 $87,225.12 2,559,741 2017-08-28 Filing
RARE $52.40 5,853 $306,697.20 2,558,094 2017-08-28 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RARE $42.48 25,000 $1,062,000.00 2,158,985 2025-02-28 Filing
RARE $42.10 73,434 $3,091,571.40 641,731 2025-03-03 Filing
RARE $42.23 11,727 $495,231.21 2,183,985 2024-12-30 Filing
RARE $50.00 8,273 $413,650.00 2,195,712 2024-12-10 Filing
RARE $55.85 20,000 $1,117,000.00 2,223,985 2024-09-03 Filing